The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
The Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 56.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 13.30 | 5.3 Bil | Healthcare |
UnitedHealth Group Inc | 8.21 | 3.3 Bil | Healthcare |
Johnson & Johnson | 6.53 | 2.6 Bil | Healthcare |
Merck & Co Inc | 6.20 | 2.5 Bil | Healthcare |
AbbVie Inc | 5.55 | 2.2 Bil | Healthcare |
Thermo Fisher Scientific Inc | 3.91 | 1.6 Bil | Healthcare |
Abbott Laboratories | 3.38 | 1.3 Bil | Healthcare |
Amgen Inc | 3.16 | 1.3 Bil | Healthcare |
Danaher Corp | 3.09 | 1.2 Bil | Healthcare |
Pfizer Inc | 2.92 | 1.2 Bil | Healthcare |